Walter De Brouwer, a co-founder, stepped down from CEO in April 2016, and Jaime Tenedorio was promoted to Chief Executive Officer [REF].
The company includes team members specializing in the fields of design, hardware, software, algorithm development, regulatory, clinical testing, manufacturing, and in-vitro diagnostics.